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Objective: The aim of this study was to assess the outcome of infrapopliteal bypass when an adjuvant arteriovenous (AV)
fistula was reconstructed as means of rescue as a result of poor runoff. The design was a retrospective multicenter
case-control study.
Methods: Seventy-seven infrapopliteal vein bypasses required an adjuvant AV fistula among 1813 patients operated on for
critical leg ischemia in 3 vascular centers between 1996 and 2003. The mean age was 74 years (range, 39-90 years). A total
of 70% of the patients had diabetes, and 24% had undergone previous vascular surgery. In 25% of the bypasses, the distal
anastomosis was in a crural artery, in 55% it was in the dorsal pedal artery, and in 20% it was in a plantar artery. An
adjuvant AV fistula was reconstructed in all cases because of poor intraoperative arterial status, intraoperative angiogra-
phy, or low intraoperative flow. A control group was retrieved that matched the study group according to the recipient
artery and runoff score.
Results:The primary and secondary patency were 61% and 75%, respectively, at 1 year in the AV fistula group and 57% and
71% in the control group. The 3-year patency rates were 49% and 62% for the AV fistula group and 46% and 71% for the
control group, respectively. There was a 76% leg-salvage rate at 3 years in the study group, compared with 87% in the
control group. There were no major complications related to the AV fistula. Intraoperative flow was increased from a
median of 20 mL/min to 115 mL/min by the AV fistula (P  .003). The graft flow was significantly higher in the AV
fistula group than in the control group (P  .001).
Conclusions: The adjuvant AV fistula increased graft flow significantly in a poor-outflow venous bypass. In this extreme
patient group, acceptable patency and leg salvage was achieved without adverse effects. Despite this, the AV fistula did not
improve the outcome. (J Vasc Surg 2006;44:985-92.)Autogenous vein bypass with the great saphenous vein
graft is the gold standard for an infrapopliteal bypass. Good
long-term results in both patency and leg salvage have been
achieved.1-3 The patency of a bypass with an arm or com-
posite vein graft has also been reported to be better than
that of a prosthetic bypass.4-6 Furthermore, successful out-
come has been reported even with blind segment bypass
grafting.7,8
An adjuvant arteriovenous (AV) fistula in combination
with a prosthetic bypass significantly increases graft flow.9,10
It has also been established that low graft flow predicts
infrainguinal vein graft failure.11,12 However, no contem-
porary clinical series exist with regard to the use of an
adjuvant AV fistula in an infrapopliteal venous bypass. The
objective of this study was to assess whether an adjuvant AV
fistula would have a beneficial effect on a venous bypass
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MATERIALS AND METHODS
This study was a retrospective multicenter study. Hos-
pital data and vascular registries were searched in three
active vascular centers in Finland: Department of Vascular
Surgery, Helsinki University Central Hospital; Department
of Surgery, Vaasa Central Hospital; and Department of
Surgery, Etelä-Karjala Central Hospital. All centers are very
active in infrainguinal bypass grafting, use the same stan-
dards, have low amputation rates, and keep local vascular
registries.13 The national vascular registry, Finnvasc, was
used up to the time it existed, ie, until December 31, 1999.
Altogether, 1813 infrainguinal bypass procedures were per-
formed between 1996 and 2003 in the three centers.
The study group comprises 77 cases representing pa-
tients who underwent infrapopliteal autogenous bypass
procedures performed with an adjuvant AV fistula. This
sample (AV fistula group) represented 4% of all infraingui-
nal bypass procedures performed during the study period.
Control patients randomly retrieved from the three
centers were matched with each case according to the
outflow artery and runoff score. Cases and controls were
operated on during the same time period. There were no
marked differences between the two groups in the demo-
graphic data (Table I).
Before surgery, all patients had been assessed by ankle-
brachial index (ABI) measurements, and the status of the
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was performed with selective antegrade digital subtraction
angiography. For this study, the angiographic images were
scored according to the guidelines of the Ad Hoc Commit-
tee14 by an experienced angioradiologist blinded to patient
data. In some cases, the preoperative angiographic images
were not sufficient for scoring, and for this reason intraop-
erative angiographic studies were used as an aid for scoring.
The runoff scores were available for 56 (73%) patients from
the patient group with AV fistulas. Because all patients
retrieved for the control group were scored for runoff,
runoff data were available for each of them. Control pa-
tients for the cases without runoff score were selected from
a sample of controls with runoff scores ranging from 4 to
10. The frequency of the different runoff scores in the AV
fistula group was thus matched with that of the control
group.
All patients had critical ischemia. The indication for
surgery was rest pain in 9%, whereas 91% of the patients had
ischemic tissue lesions in the AV fistula group. In the
control group, the corresponding percentages were 18%
and 82%.
Only patients with an autogenous vein graft bypass to
either a crural or a pedal artery with an adjuvant AV fistula
were included in the AV fistula group. The inflow artery
was at the femoral level in 57 (74%) cases and at the
popliteal level in 20 (26%) cases in the AV fistula group, and
it was at the femoral level in 75% and at the popliteal level in
25% in the control group. The patients were matched
according to the outflow artery: in 19 (25%) patients, the
distal anastomosis was at the crural level, and in 58 (75%) it
was in a pedal artery.
Autogenous vein grafts were always used. In the case
group, the AV fistula was of the common ostium type in 60
(78%), was proximal to the anastomosis in 9 (12%), and was
a modified fistula in 8 (10%) patients. The modified fistula
represented a configuration in which the fistula was made
directly on the vein graft on the distal anastomosis without
redoing the entire anastomosis (Table II; Fig 1).
In the AV fistula group, the decision to use an adjuvant
AV fistula was always made during the operation. In 50
Table I. Demographics of the patient groups
Clinical characteristic AV fistula group Control group
Age, y, mean (range) 74 (39-90) 75 (46-93)
Sex (male/female) 42/35 37/40
Coronary artery disease 45 (61%) 42 (55%)
Diabetes 52 (70%) 44 (57%)
Hypertension* 31 (42%) 28 (36%)
Renal failure† 13 (18%) 12 (16%)
Preoperative ABI, median
(range)‡
0.40 (0-1.18) 0.37 (0-0.91)
AV, Arteriovenous; ABI, ankle-brachial index.
*Blood pressure more than 150/90 mm Hg.
†Serum creatinine level more than 150 mol/L.
‡Excluding mediasclerotic values greater than 1.5.(65%) cases, the status of the outflow artery was clinicallydeemed very poor; ie, the artery was heavily calcified or was
very small in diameter, there was minimal backflow, or a
1-mm soft coronary probe failed to pass longer than 1 to
2 cm of the recipient segment. The findings in intraopera-
tive angiography indicated a need for an adjuvant AV fistula
in 15 (20%) cases when practically no outflow bed was
visualized distal to the distal anastomosis. In eight cases
(10%), very low flow was measured after the completion of
the distal anastomosis. In these patients, the flow values
varied between 10 and 20 mL/min, except for one patient
with a flow value of 30 mL/min. Thus, a flow value less
than 20 mL/min was generally regarded as too low to
maintain graft patency. Therefore, when no technical fail-
ure was found, an AV fistula was made to improve flow and
prevent graft thrombosis. In four cases (5%), the adjuvant
AV fistula was used at reoperation after an immediate
thrombosis (1-4 days) of an infrapopliteal bypass graft.
Because flowmetry was not uniformly available in the
beginning of the study, intraoperative flow measurements
were performed in 39 cases in the AV fistula group and in
61 cases in the control group. The flow was recorded with
a transit time flowmeter (CardioMed CM4006; Medistim
A/S, Oslo, Norway) after the completion of the distal
anastomosis. If the patient was considered hemodynami-
cally stable, the maximum flow capacity was recorded after
an intra-arterial papaverine hydrochloride injection (40 mg).
In 12 patients with an AV fistula, the flow was recorded both
before and after reconstruction of the AV fistula.
All patients were heparinized during arterial cross-
clamping. Low-molecular-weight heparin was adminis-
tered during the first postoperative days until the patient
was ambulatory. Long-term antiplatelet therapy was ad-
Table II. Indication, inflow and outflow artery, and graft
and fistula type of the bypasses
Variable
AV fistula
group
Control
group
Indication: rest pain 7 (9%) 14 (18%)
Ulcer 47 (61%) 44 (57%)
Gangrene 23 (30%) 19 (25%)
Inflow: common femoral 28 (36%) 42 (55%)
Superficial femoral 29 (38%) 16 (21%)
Proximal popliteal 5 (6%) 3 (3%)
Distal popliteal 15 (20%) 16 (21%)
Outflow: anterior tibial 5 (6%) 5 (6%)
Posterior tibial 6 (8%) 6 (8%)
Fibular 8 (10%) 8 (10%)
Dorsal pedal 42 (55%) 42 (55%)
Common plantar 14 (18%) 16 (21%)
Tarsal 2 (3%)
Graft type: great saphenous vein 63 (82%) 67 (87%)
Arm vein 9 (12%) 2 (3%)
Spliced vein 5 (6%) 8 (10%)
Fistula type: common ostium 60 (78%)
Proximal 9 (12%)
Modified 8 (10%)
AV, Arteriovenous.ministered with acetylsalicylic acid 100 mg daily unless the
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itant disease.
All three units of this study used the same vein graft
surveillance schedule with clinical outpatient visits, ABI
measurements, and duplex examinations. During the first
postoperative year, the visits were at 1, 3, and 6 months,
after which the patients were generally surveyed every 6
months. The follow-up time ranged from2months to 8 years.
Primary patency, assisted primary patency, secondary
patency, and limb salvage were defined according to the Ad
Hoc Committee’s reporting standards.14
The life-table method, Kaplan-Meier analysis, and the
Fig 1. Schematic illustration of (a) the common ostium arterio-
venous (AV) fistula, (b) the proximal AV fistula, and (c) the
modified AV fistula.log-rank test were used for survival analysis. The 2 test, theWilcoxon test, and the Mann-Whitney U test were used in
analysis of the nonparametric data and the parametric data
with skewed distribution (SPSS for Windows, version 11.0;
SPSS, Chicago, Ill).
RESULTS
Immediate results (<30 days). There were 10 imme-
diate occlusions in the AV fistula group and 7 in the control
group. Revision and thrombectomy was performed in three
instances (in one of the patients twice) in the AV fistula
group. In one case, thrombolysis of the graft yielded sec-
ondary patency at 4 weeks. A redo operation was chosen in
one patient; a polytetrafluoroethylene bypass was per-
formed. Of the five cases treated conservatively, two under-
went amputation within 1 month, and two did so at a later
date. In one patient, amputation was not necessary despite
an occluded graft before the patient was lost to follow-up at
16 months.
In the control group, the immediate occlusions re-
sulted in revision and thrombectomy in two patients who
achieved secondary patency. Five patients were treated
conservatively, and this resulted in early amputation in two
patients and a late amputation in one patient. A late redo
operation was performed in one case, and one patient was
lost to follow-up at 7 weeks with an occluded graft.
Altogether, 10 other procedures were performed in the
AV fistula group during the immediate postoperative pe-
riod: a revision of a patent vein graft, amputation due to
progressive gangrene despite an open graft, and 8 revisions
or minor amputations to treat foot ulcers. In the control
group, two patent vein grafts were revised as a result of the
findings on duplex surveillance. Twenty-one patients had a
minor amputation or wound revision performed, and this
was performed for postoperative wound infection in seven
cases (Table III).
One patient with a patent graft died in the immediate
postoperative period in the AV fistula group, and two did so
in the control group. Ten (13%) patients in the AV fistula
group and 11 (14%) in the control group had general
complications. There were 12 (16%) patients with surgical
complications in the immediate postoperative period in the
AV fistula group and 25 (33%) in the control group (Table
IV).
Patency. Primary patency of the vein graft was 61%
and 49% at 1 and 3 years, respectively, in the AV fistula
group and was 57% and 46% in the control group during
the same time periods. Assisted primary patency and sec-
ondary patency rates were 67% and 75% at 1 year and 58%
and 62% at 3 years, respectively, for the AV fistula group.
Assisted primary patency and secondary patency rates for
the control group were 70% and 71% at 1 and 3 years,
respectively (Fig 2).
Leg salvage and amputation-free survival. The leg-
salvage rate was 83% at 1 year and 76% at 3 years in the AV
fistula group, compared with the 87% leg-salvage rate of the
control group. The survival of the patients was 79% and
52% at 1 and 3 years, respectively, for the AV fistula group
and was 85% and 58% for the control group. Accordingly,
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was 64% and 40% at 1 and 3 years and was 77% and 54% for
the control group for the same time periods (Fig 3).
The life-table and Kaplan-Meier analyses were per-
formed between all cases and controls, as well as the 56
patients scored for runoff in the AV fistula group and the 56
matching patients in the control group. A statistical differ-
ence between the groups was not found in either analysis.
Reoperations. Thirty reoperations were performed
during follow-up in the AV fistula group and 23 in the
control group. Twenty-four reoperations were performed
because graft stenoses were detected in the duplex surveil-
lance (Table III).
Hemodynamic measurements. The median ABI was
1.00 in the AV fistula group and was 0.99 in the control
group after the operation, compared with the preoperative
values of 0.40 and 0.37 (excluding mediasclerotic values
more than 1.5). In the group of patients with an AV fistula,
49 (88%) of 56 angiographies sufficient for scoring had a
runoff score of 7 or more. The runoff scores of the control
group matched the scores of the AV fistula group. There
was no difference in the runoff score between the patients
with patent and immediately occluded grafts (P  .79) in
either group or in the analysis of the entire patient popula-
tion. When a cutoff value of 7 was tested, there was no
Table III. Immediate (30 days) and late reoperations
Operation type Immediate A
Thrombectomy  revision 4
Redo bypass operation 1
Thrombolysis 1
Hemostasis 5
Correction of graft rupture 2
Inflow PTA —
Correction/revision of open graft 1
Closure of in situ graft patent vein branch —
Wound revision/minor amputation 8
AV, Arteriovenous; PTA, percutaneous transluminal angioplasty.
Table IV. Immediate (30 days) postoperative
complications
Complication type
AV fistula
group
Control
group
General: acute myocardial infarction 1 —
Cardiac insufficiency* 7 7
Pneumonia 1 1
Stroke 1 1
Sepsis — 1
Acute renal failure — 1
Surgical: superficial wound infection 5 14
Deep infection — 5
Hematoma/hemorrhage 7 4
Seroma — 2
AV, Arteriovenous.
*Postoperative temporary state of cardiac insufficiency necessitating extra
care or medication for more than the first postoperative day.difference in patency between the patients with a runoffscore of at least 7 or lower than 7 (P  .92). Furthermore,
the patients with a completely obstructed pedal arch (giv-
ing a runoff score of 10) achieved patency rates equivalent
to those of the rest of the study group.
The median flow after the completion of the fistula was
110 mL/min (range, 10-400 mL/min). In a subgroup of
12 patients, the flow was measured both before the recon-
struction of the fistula and after it, giving median flow
values of 20 mL/min (range, 10-60 mL/min) and 115
mL/min (range, 10-350 mL/min), respectively (P 
.003). The median flow of 60 mL/min (range, 10-176
mL/min) in the control group was significantly lower than
in the group with AV fistula (P  .001). The flow values
increased to equal levels in the two groups after the vaso-
dilatation caused by papaverine injection (maximum flow
capacity) despite the open fistula in the AV fistula group
( P  .92; Fig 4).
The patency rates did not differ between the pedal and
the crural bypasses in either the AV fistula or the control
group (P  .84), even though there was a significant
difference in the respective median graft flows (60 vs 93
mL/min; P .003). The median flow in the patient group
with immediately failed grafts (29 mL/min) was signifi-
cantly lower than in patients with patent grafts (80 mL/
min; P  .007). Despite the reconstruction of the fistula,
the flow values did not increase in some (n 4) patients in
the group with failed grafts. In the control group, three
patients had a low flow value measured (20 mL/min)
after the completion of the distal anastomosis, and this
would have been considered an indication to reconstruct an
AV fistula in the AV fistula group. These patients had,
however, a good vasodilatation response to papaverine.
Three of the seven patients with postoperative cardiac
insufficiency in the AV fistula group had a flow value above
the median graft flow. Despite this, all the patients recov-
ered uneventfully.
DISCUSSION
Poor angiographic outflow status identified in the cru-
ral or pedal arteries is reported to indicate poor limb
outcome after infrapopliteal bypass surgery.15-17 In this
series, the status at the operation was found to be even
worse than anticipated. For this reason, as means of rescue,
ula Control Late AV fistula Control
2 5 4
— 5 5
— — 1
1 — —
— — —
— 2 1
2 12 12
— 4 —
21 2 —V fistan adjunctive method was regarded as necessary.
) and
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thetic bypass to increase graft flow above the thrombotic
threshold.9,18 When the patients in this series underwent
operation, the final results of the randomized trials with
prosthetic grafts and AV fistulas were not available. The
rationale of applying an AV fistula was based on the throm-
botic threshold theory: even an autogenous graft with a
very low flow, which is due to poor outflow status, might
thrombose if the graft flow does not increase above a
certain threshold level. Randomized trials published later
failed to show a benefit in patency,19,20 but the fistula did
increase the graft flow.
The patients with an adjuvant AV fistula represent a
very marginal patient population who underwent operation
in the three centers during the study period. The poor
status of the outflow artery was the main reason to recon-
struct the fistula, and, therefore, a control group with an
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The runoff score is a grading system of the outflow
based on preoperative angiographic images.14 A few studies
have been published with regard to the predictive value of
the runoff score on the outcome, with conflicting re-
sults.8,15-17,21,22 Desai et al8 reported secondary patency
and a leg-salvage rate of 67% at 2 years after crural artery
bypass in a group with blind outflow. In the current series,
the poor outflow was reflected by the high runoff score,
which, however, did not have any predictive value on the
final outcome.
In this study, the final decision to use an adjuvant fistula
was made by clinical judgment despite the preoperative
angiographic information. Because pedal arteries may be
poorly visualized on the angiographic images, assessment
6054484236
Secondary patency
60544842363024181260
1,0
,8
,6
,4
,2
0,0
   17              13              8 
   16              12              9
77   46     37               22              17              13               8
77   51     39               24              16              12               9
dary patency of patients with infrapopliteal vein graft
without AV fistula (AVF, red line). SE, 5.7% to 8.5%.
6054484236
Amputation free survival
60544842363024181260
1,0
,8
,6
,4
,2
0,0
      38              29              22 
      20              17              14 
77   54     44             34              27             23             18
77   59     46             29              20             17             14
utation-free survival of patients with infrapopliteal vein
) and without AV fistula (AVF, red line). SE, 4.4% toncy
30
           
           
secon3024
45        
29        
d amp
lineof the outflow artery sometimes has to be performed by
hich d
JOURNAL OF VASCULAR SURGERY
November 2006990 Laurila et alother means—sometimes only clinically, as described in a
study on bypasses to the plantar and tarsal arteries.23 In our
study, the status of the outflow artery was always judged
clinically, which, of course, was a subjective assessment of
the need for adjunctive methods. Intraoperative angiogra-
phy was used in only a subgroup of patients.
Low intraoperative flow has been found to be an inde-
pendent risk factor for graft thrombosis.11,12 In this study,
the flow values in the AV fistula group improved signifi-
cantly after the reconstruction of the AV fistula, but in the
end this did not result in any benefit in patency.
There was an equally good vasodilatation response in
both groups. The vasodilatation effect represents the capac-
ity of the outflow bed, which was not augmented by the AV
fistula. A high vasodilatation effect has been shown to
predict good outcome of an infrapopliteal bypass.12 The
flows were significantly higher in the grafts that stayed
patent than in the immediately occluded grafts irrespective
of the use of the AV fistula. Therefore, it seems that a
high-enough rest flow and vasodilatation effect predict
good patency, even though there are also other factors that
affect patency and outcome. In the group of the immedi-
ately failed grafts, the flow did not increase despite recon-
struction of the AV fistula in a few patients, thus suggesting
immediate thrombosis of the fistula in some cases.
The role of augmented graft flow by the fistula on graft
stenosis is unclear. However, Ihlberg et al11 have shown
that the higher the graft flow achieved at operation, the
fewer de novo graft stenoses occur. There were, however,
an equal number of reoperations due to graft stenosis in
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Fig 4. Boxplots for intraoperative graft flow and maxim
control group; flow was measured with an open AV fis
significant difference between the groups in rest flow, wboth groups in the present study.There were no adverse effects caused by the AV fistula
and were no additional operations or general complications
due to the increased flow. It has been shown in previous
series of adjuvant AV fistula and prosthetic bypass that
adverse effects are rare.9,20
Contrary to what was expected, there was no difference
in patency or leg salvage between the case and control
groups. Furthermore, there was no difference in outcome
according to the outflow level. A total of 75% of the
bypasses in this study were performed to pedal arteries.
Pomposelli et al24 have reported a series of more than 1000
pedal bypasses with primary and secondary patency and
leg-salvage rates of 57%, 63%, and 78% at 5 years. In
Hughes and colleagues’23 report of bypasses to plantar and
tarsal arteries, the 5-year primary and secondary patencies
were 41% and 50%, and the leg-salvage rate was 69%. Crural
bypasses are reported to yield patencies varying between
60% and 82% and limb salvage rates of 67% to 88% at 3 to 5
years.1,2,25-27 Despite the unfavorable preoperative status
in both the case and control groups, our current results
correspond to the results mentioned previously.
Even though there are a number of studies on the effect
of an AV fistula on prosthetic bypass, to our knowledge,
there are no previous publications of an AV fistula com-
bined with a venous bypass. Our current series is a retro-
spective case series with matched controls and is thus able
to provide level III evidence at best. There was no statistical
difference in either patency or leg salvage between the
patient groups despite the augmented graft flow in the AV
fistula group. This series does not indicate any benefit from
Maximum flow capacity
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ow capacity in the arteriovenous (AV) fistula group and
in the AV fistula (Avf) group. There was a statistically
isappeared with the papaverine-induced vasodilatation.um fl
tulaan adjuvant AV fistula in a venous bypass, even though the
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policy on infrapopliteal autogenous bypass is, however,
justified because even with poor runoff and intraoperative
status, acceptable long-term patency and leg salvage can be
achieved.
CONCLUSION
This series contained bypasses with such poor periop-
erative outflow status that the operating surgeon decided to
use adjunctive measures to save a graft that, in his opinion,
was otherwise likely to fail. In this situation, an adjuvant AV
fistula was created as means of rescue to improve graft flow
and, thus, possibly patency. Compared with a control
group with equally poor outflow, no difference in patency
or leg salvage was achieved despite the improved graft flow.
Hence, it can be concluded that in this extreme group with
critical limb ischemia, an adjuvant AV fistula offers no
additional benefit.
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